ORPHARM S A is a full-service distribution company specializing in the rare disease and oncology segments of the pharmaceutical market, based in Buenos Aires, Argentina. The company provides a one-stop solution for rare and orphan products, acting as an extension of pharmaceutical partners' local operations by performing all services needed to bring products to patients. Its core pillars include service mentality, rare and orphan product experience focused on named patient and reimbursed success, and a corporate structure positioned to find, recruit, fund, and deliver patients. Founded in 2019, the company emphasizes compliance and high ethical standards to differentiate itself in the region.
| Import | Export |
|---|---|
|
Trade Records
456
|
Trade Records
253
|
|
Suppliers
-
|
Buyers
-
|
|
Latest Import Date
2026-06
|
Latest Export Date
2026-06
|
According to Topease's global trade data, ORPHARM S A exports products to verified importers across global markets.
Its export activity is associated with HS-code categories such as:
As an importer, ORPHARM S A sources products from verified exporters across multiple regions.
Its import activity spans HS-code categories including:
Explore ORPHARM S A's import activity, including trade volumes, top suppliers, sourcing countries, and key product categories. These insights allow exporters and potential suppliers to understand its global supply chains, track procurement trends, and identify new business opportunities.
Gain insights into ORPHARM S A's export activities, including shipment volumes, key buyers, destination countries, and product categories. Understand global demand patterns, track sales reach, and spot opportunities to connect with potential buyers.
Access ORPHARM S A's key professional contacts for B2B outreach purposes. View verified phone numbers, emails, and LinkedIn profiles to facilitate efficient business communication.
Disclaimer: Data is compiled from public and third-party sources and may not be complete or fully accurate. This information is provided for business intelligence purposes only and should not be used for legal, financial, or compliance decisions.